Cyclooxygenase-2: A novel target in human solid tumors
- Maria Rosaria RaspolliniAffiliated withDepartment of Human Pathology and Oncology, University of Florence, School of Medicine Email author
- , Gian Luigi Taddei
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
The enzyme cyclooxygenase-2, which is involved in the conversion of arachidonic acid-to-prostanoid synthesis, plays a key role in many inflammatory and proliferative reactions. Experimental data have shown that prostaglandins have a central action in therapeutic targeting not only in the treatment of many inflammatory diseases but also in several types of human cancers. Inhibitors of cyclooxygenase activity seem to protect against carcinoma development and show promise as chemopreventive agents and possible target therapies. Data support new treatments for patients with solid cancers tailored to the molecular characteristics of the individual tumor.
- Cyclooxygenase-2: A novel target in human solid tumors
Current Oncology Reports
Volume 9, Issue 2 , pp 96-101
- Cover Date
- Print ISSN
- Online ISSN
- Current Science Inc.
- Additional Links